Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer With Brain Metastases
Interventions: DRUG: pyrotinib+capecitabine+bevacizumab
Sponsor: Tongji Hospital